This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: The University of British Columbia, Promis Neurosciences Inc.. Active years: 2022-2025.
Company Filing History:
2 out of 959 
1 out of 9 Years Active: 2022-2025
Title: Xubiao Peng: Innovator in Neurobiology
Introduction
Xubiao Peng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of neurobiology, particularly in understanding the mechanisms of neurodegenerative diseases. With a total of 2 patents, his work focuses on the development of specific antibodies that target misfolded proteins associated with these conditions.
Latest Patents
Xubiao Peng's latest patents include groundbreaking research on conformational epitopes in alpha-synuclein. The first patent discusses antibodies that selectively recognize misfolded oligomeric alpha-synuclein, which are crucial for inhibiting its propagation and toxicity. The second patent pertains to epitopes in the RNA recognition motif 1 (RRM1) of TDP-43, along with methods for creating immunogens and antibodies specific to these conformational epitopes.
Career Highlights
Throughout his career, Xubiao Peng has worked with esteemed institutions such as the University of British Columbia and Promis Neurosciences Inc. His research has significantly advanced the understanding of neurodegenerative diseases and the development of therapeutic strategies.
Collaborations
Xubiao has collaborated with notable scientists, including Steven S. Plotkin and Neil R. Cashman. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Xubiao Peng's innovative work in neurobiology and his patents on antibodies targeting misfolded proteins highlight his significant contributions to science. His research continues to pave the way for potential therapeutic advancements in treating neurodegenerative diseases.